GSK 656398

Drug Profile

GSK 656398

Alternative Names: GSK-656398; TD-5742

Latest Information Update: 13 Jun 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Theravance
  • Class Bronchodilators
  • Mechanism of Action Muscarinic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Chronic obstructive pulmonary disease

Most Recent Events

  • 12 May 2006 Discontinued - Phase-I for Chronic obstructive pulmonary disease in USA (Inhalation)
  • 19 Aug 2005 Phase-I clinical trials in Chronic obstructive pulmonary disease in USA (Inhalation)
  • 31 Jul 2004 Preclinical trials in Chronic obstructive pulmonary disease in USA (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top